ANXA10 and hilar cholangiocarcinoma: Sun et al. reported that ANXA10 promotes the progression of perihilar cholangiocarcinoma and facilitated metastasis by promoting the epithelial-mesenchymal transition (EMT) process via the PLA2G4A/PGE2/STAT3 pathway [19].